CVS
February 7, 2024 - AI Summary
Undervalued by 8% based on the discounted cash flow analysis.
Market cap | $98.50 Billion |
---|---|
Enterprise Value | $148.65 Billion |
Dividend Yield | $2.4486 (3.13%) |
Earnings per Share | $6.47 |
Beta | 0.46 |
Outstanding Shares | 1,258,449,553 |
Avg 30 Day Volume | 8,159,787 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 11.8 |
---|---|
PEG | -106.15 |
Price to Sales | 0.28 |
Price to Book Ratio | 1.32 |
Enterprise Value to Revenue | 0.42 |
Enterprise Value to EBIT | 10.18 |
Enterprise Value to Net Income | 17 |
Total Debt to Enterprise | 0.41 |
Debt to Equity | 0.81 |
No data
No data